IFNAR1 and neoplasm: This is in line with reports of VSV treatment on B16 tumours with rapid induction of cytokines with anti-tumour activity.25 However, in our setting with LLC1-IFNAR1−/− tumours these proinflammatory signals are likely facilitators of the dominating antiviral immune response.